Cargando…

Dimerization of Transmembrane Proteins in Cancer Immunotherapy

Transmembrane proteins (TMEMs) are integrated membrane proteins that span the entire lipid bilayer and are permanently anchored to it. TMEMs participate in various cellular processes. Some TMEMs usually exist and perform their physiological functions as dimers rather than monomers. TMEM dimerization...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lei, Li, Jingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143916/
https://www.ncbi.nlm.nih.gov/pubmed/37103820
http://dx.doi.org/10.3390/membranes13040393
_version_ 1785033974907666432
author Li, Lei
Li, Jingying
author_facet Li, Lei
Li, Jingying
author_sort Li, Lei
collection PubMed
description Transmembrane proteins (TMEMs) are integrated membrane proteins that span the entire lipid bilayer and are permanently anchored to it. TMEMs participate in various cellular processes. Some TMEMs usually exist and perform their physiological functions as dimers rather than monomers. TMEM dimerization is associated with various physiological functions, such as the regulation of enzyme activity, signal transduction, and cancer immunotherapy. In this review, we focus on the dimerization of transmembrane proteins in cancer immunotherapy. This review is divided into three parts. First, the structures and functions of several TMEMs related to tumor immunity are introduced. Second, the characteristics and functions of several typical TMEM dimerization processes are analyzed. Finally, the application of the regulation of TMEM dimerization in cancer immunotherapy is introduced.
format Online
Article
Text
id pubmed-10143916
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101439162023-04-29 Dimerization of Transmembrane Proteins in Cancer Immunotherapy Li, Lei Li, Jingying Membranes (Basel) Review Transmembrane proteins (TMEMs) are integrated membrane proteins that span the entire lipid bilayer and are permanently anchored to it. TMEMs participate in various cellular processes. Some TMEMs usually exist and perform their physiological functions as dimers rather than monomers. TMEM dimerization is associated with various physiological functions, such as the regulation of enzyme activity, signal transduction, and cancer immunotherapy. In this review, we focus on the dimerization of transmembrane proteins in cancer immunotherapy. This review is divided into three parts. First, the structures and functions of several TMEMs related to tumor immunity are introduced. Second, the characteristics and functions of several typical TMEM dimerization processes are analyzed. Finally, the application of the regulation of TMEM dimerization in cancer immunotherapy is introduced. MDPI 2023-03-30 /pmc/articles/PMC10143916/ /pubmed/37103820 http://dx.doi.org/10.3390/membranes13040393 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Li, Lei
Li, Jingying
Dimerization of Transmembrane Proteins in Cancer Immunotherapy
title Dimerization of Transmembrane Proteins in Cancer Immunotherapy
title_full Dimerization of Transmembrane Proteins in Cancer Immunotherapy
title_fullStr Dimerization of Transmembrane Proteins in Cancer Immunotherapy
title_full_unstemmed Dimerization of Transmembrane Proteins in Cancer Immunotherapy
title_short Dimerization of Transmembrane Proteins in Cancer Immunotherapy
title_sort dimerization of transmembrane proteins in cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143916/
https://www.ncbi.nlm.nih.gov/pubmed/37103820
http://dx.doi.org/10.3390/membranes13040393
work_keys_str_mv AT lilei dimerizationoftransmembraneproteinsincancerimmunotherapy
AT lijingying dimerizationoftransmembraneproteinsincancerimmunotherapy